Skip to content
Search

Latest Stories

PDA: Current NHS pharmacy services unlikely to permit pharmacy technicians to operate under PGDs

PDA: Current NHS pharmacy services unlikely to permit pharmacy technicians to operate under PGDs
The Pharmacists' Defence Association (PDA) has issued an advisory notice to its members  regarding the latest amendments made to the Human Medicines Regulations made effective starting 26 June 2024

According to the legislative changes,  pharmacy technicians (PTs) can now supply and administer medicines under Patient Group Directions (PGDs) in England, Scotland, and Wales, however  Pharmacists' Defence Association (PDA) says it is only in theory.

The defence association has said that practical implementation requires additional steps which under the current service directions and specifications for community pharmacy NHS commissioned services "will likely not permit PTs to work under them".


It will therefore "be premature to offer specific operational advice to pharmacists involved in the delivery of current community pharmacy NHS commissioned services, involving PGDs" as these are subject to negotiation and necessitate amendments.

PDA has informed its members that these changes should be expected from the respective country pharmacy negotiating bodies in due course.

Advising its members that current NHS commissioned services involving PGDs stipulate that only pharmacists can deliver these services, the association has reiterated key principles regarding PGDs.

A PGD is a legal mechanism allowing the supply of certain prescription-only medicines (POMs) without a prescription.

The PDA highlighted two crucial components of safe medicines supply identified during the Department of Health and Social Care (DHSC) consultation on supervision in community pharmacy:

  1. Preparation, Assembly, Sale, and Supply of Medicines: These activities, which include an accuracy check, can be undertaken by registered pharmacy technicians.
  2. Clinical Assessment: This task is reserved solely for pharmacists due to their comprehensive training and qualifications.

The PDA underscored that PGDs typically require "a clinical assessment" to establish a diagnosis, ensure the correct PGD is chosen, and address "potential interactions with complex polypharmacy regimes or co-morbidities".

Unlike the dispensing process, PGDs cannot be segmented into smaller tasks.

They are designed to be delivered as a single episode of care by one person.

"Consequently, when the patient safety consideration logic on medicines supply carries through to PGDs it dictates that only pharmacists should be delivering any PGD that involves an element of clinical assessment," the notice stated.

Moreover, these changes do not apply to Northern Ireland, where pharmacy technicians are not regulated.

More For You

Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less